Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Economy of the United States
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Outcomes=== The U.S. lags in overall healthcare performance but is [[Biomedical research in the United States|a global leader in medical innovation]]. America solely developed or contributed significantly to nine of the top ten most important medical innovations since 1975 as ranked by a 2001 poll of physicians, while the EU and Switzerland together contributed to five. Since 1966, Americans have received more [[List of Nobel laureates in Physiology or Medicine|Nobel Prizes in Medicine]] than the rest of the world combined. From 1989 to 2002, four times more money was invested in private biotechnology companies in America than in Europe.<ref>{{cite news |last= Cowen |first=Tyler |title=Poor U.S. Scores in Health Care Don't Measure Nobels and Innovation |url= https://www.nytimes.com/2006/10/05/business/05scene.html?_r=1& |access-date=October 9, 2012 |newspaper=The New York Times |date=October 5, 2006}}</ref><ref>{{cite web |author1=Whitman, Glen |author2=Raad, Raymond |title=Bending the Productivity Curve: Why America Leads the World in Medical Innovation |url= http://www.cato.org/publications/policy-analysis/bending-productivity-curve-why-america-leads-world-medical-innovation |publisher=The Cato Institute |access-date=October 9, 2012}}</ref> Of 17 high-income countries studied by the [[National Institutes of Health]] in 2013, the United States ranked at or near the top in obesity rate, frequency of automobile use and accidents, homicides, [[infant mortality]] rate, incidence of heart and lung disease, sexually transmitted infections, adolescent pregnancies, recreational drug or alcohol deaths, injuries, and rates of disability. Together, such lifestyle and societal factors place the U.S. at the bottom of that list for life expectancy. On average, a U.S. male can be expected to live almost four fewer years than those in the top-ranked country, though Americans who reach age 75 live longer than those who reach that age in peer nations.<ref name=nihbph>{{cite book|url=http://books.nap.edu/openbook.php?record_id=13497 |title="U.S. Health in International Perspective: Shorter Lives, Poorer Health" (2013) National Institutes of Health Committee on Population, Board on Population Health and Public Health Practice |year=2013 |publisher=Books.nap.edu |doi=10.17226/13497 |pmid=24006554 |isbn=978-0-309-26414-3 |access-date=October 20, 2013|author1=National Research Council (US) |last2=Woolf |first2=S. H. |last3=Aron |first3=L. }}</ref> One consumption choice causing several of the maladies described above are cigarettes. Americans smoked 258 billion cigarettes in 2016.<ref name="CDCTobaccoFree">{{cite web|url=https://www.cdc.gov/tobacco/data_statistics/fact_sheets/economics/econ_facts/index.htm|title=Economic Trends in Tobacco|last=CDCTobaccoFree|date=May 4, 2018|website=Centers for Disease Control and Prevention|language=en-us|access-date=June 3, 2019 }}</ref> Cigarettes cost the United States $326{{spaces}}billion each year in direct healthcare costs ($170{{spaces}}billion) and lost productivity ($156{{spaces}}billion).<ref name="CDCTobaccoFree" /> A comprehensive 2007 study by European doctors found the five-year [[cancer]] survival rate was significantly higher in the U.S. than in all 21 European nations studied, 66.3% for men versus the European mean of 47.3% and 62.9% versus 52.8% for women.<ref>{{cite news|last=Martin|first=Nicole|title=UK cancer survival rate lowest in Europe|url=https://www.telegraph.co.uk/news/uknews/1560849/UK-cancer-survival-rate-lowest-in-Europe.html |archive-url=https://ghostarchive.org/archive/20220111/https://www.telegraph.co.uk/news/uknews/1560849/UK-cancer-survival-rate-lowest-in-Europe.html |archive-date=January 11, 2022 |url-access=subscription |url-status=live|access-date=August 19, 2013|newspaper=The Daily Telegraph|date=August 21, 2007}}{{cbignore}}</ref><ref>{{cite journal|last=Verdecchia|first=A|author2=Francisci, S |author3=Brenner, H |author4=Gatta, G |author5=Micheli, A |author6=Mangone, L |author7=Kunkler, I |author8= EUROCARE-4 Working, Group |title=Recent cancer survival in Europe: a 2000β02 period analysis of EUROCARE-4 data|journal=The Lancet Oncology|date=September 2007|volume=8|issue=9|pages=784β96|pmid=17714993|doi=10.1016/s1470-2045(07)70246-2}}</ref> Americans undergo cancer screenings at significantly higher rates than people in other developed countries, and access [[Magnetic resonance imaging|MRI]] and [[CT scan]]s at the highest rate of any OECD nation.<ref name=Atlas>{{cite book|last=MD|first=Scott W. Atlas|title=In excellent health : setting the record straight on America's health care and charting a path for future reform|year=2011|publisher=Hoover Institution Press, Stanford University|location=Stanford, California|isbn=978-0817914448|pages=199β205|url=https://books.google.com/books?id=0qExi2-3m5IC}}</ref> People in the U.S. diagnosed with [[Hypercholesterolemia|high cholesterol]] or [[hypertension]] access pharmaceutical treatments at higher rates than those diagnosed in other developed nations, and are more likely to successfully control the conditions.<ref>Atlas 2011, pp. 205β07</ref><ref>{{cite journal|last=Wolf-Maier|first=K.|title=Hypertension Treatment and Control in Five European Countries, Canada, and the United States|journal=Hypertension|date=November 24, 2003|volume=43|issue=1|pages=10β17|doi=10.1161/01.HYP.0000103630.72812.10|pmid=14638619|doi-access=free}}</ref> [[Diabetes mellitus|Diabetics]] are more likely to receive treatment and meet treatment targets in the U.S. than in Canada, England, or Scotland.<ref>Atlas 2011, pp. 150β56</ref><ref>{{cite journal |first1=June E. |last1=O'Neill |first2=Dave M. |last2=O'Neill |title=Health Status, Health Care and Inequality: Canada vs. the U.S |journal=Forum for Health Economics & Policy |volume=10 |issue=1 |doi=10.2202/1558-9544.1094 |year=2008 |s2cid=73172486 |url=http://www.nber.org/papers/w13429.pdf}}</ref> According to a 2018 study of 2016 data by the [[Institute for Health Metrics and Evaluation]], the U.S. was ranked 27th in the world for healthcare and education, down from 6th in 1990.<ref>{{cite news |last=McDonald |first=Andy |date=September 28, 2018 |title=U.S. Drops To 27th In The World For Education And Health Care|url=https://www.huffingtonpost.com/entry/whelp-the-us-now-ranks-27th-in-the-world-on-education-and-healthcare_us_5bae5d02e4b0425e3c23508f|work=The Huffington Post |access-date=October 6, 2018}}</ref>
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Economy of the United States
(section)
Add topic